About Qritive
Qritive is a company based in Singapore (Singapore) founded in 2017 by Kavita Butalia, Kaveh Taghipour, and Aneesh Sathe. Qritive has raised $7.5 million across 1 funding round from investors including Enterprise Singapore, Exfinity Venture Partners and MassMutual Ventures. Qritive offers products and services including Pantheon, QAi Prostate Services, and Other AI Modules. Qritive operates in a competitive market with competitors including PathAI, PAIGE, EnSpectra Health, Proscia and PreciseDx, among others.
- Headquarter Singapore, Singapore
- Founders Kavita Butalia, Kaveh Taghipour, Aneesh Sathe
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Qritive Ai India Private Limited
- Date of Incorporation 07 Jun, 2022
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$261.62 K (USD)0as on Mar 31, 2023
-
EBITDA
-$259.54 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$7.5 M (USD)
in 1 rounds
-
Latest Funding Round
$7.5 M (USD), Series A
Jan 09, 2023
-
Investors
Enterprise Singapore
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qritive
Qritive offers a comprehensive portfolio of products and services, including Pantheon, QAi Prostate Services, and Other AI Modules.
Dashboard for pathology case management and AI-driven image analysis
Module for analyzing prostate cancer in histopathology
Additional modules for various pathology applications and integrations
People of Qritive
Unlock access to complete
Funding Insights of Qritive
Qritive has successfully raised a total of $7.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.5 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Qritive
Qritive has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Singapore, Exfinity Venture Partners and MassMutual Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital fund
|
Locked | Locked | Locked | |
|
Investment in B2B technology ventures from India for global markets.
|
Locked | Locked | Locked | |
|
Government-backed fund investing in tech startups
|
Locked | Locked | Locked |
Investor details for Qritive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qritive
Investment portfolio details for Qritive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qritive
Detailed financials for Qritive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qritive Comparisons
Peer comparison for Qritive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qritive
Qritive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, PAIGE, EnSpectra Health, Proscia and PreciseDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-enabled tools for computational pathology and cancer diagnostics are provided.
|
|
| Locked | Locked | Locked |
Developer of medical devices for tissue imagining and cancer detection
|
|
| Locked | Locked | Locked |
Provider of an AI and cloud-based digital pathology solution for cancer diagnosis
|
|
| Locked | Locked | Locked |
AI-based medical image analysis software is provided for healthcare professionals.
|
Detailed competitors of Qritive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qritive
Complete news archive for Qritive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qritive
Qritive was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Qritive is headquartered in Singapore, Singapore.
Aneesh Sathe is the current CEO of Qritive. They have also founded this company.
Qritive is a funded company, having raised a total of $7.5M across 1 funding round to date.
Qritive was established in 2017 in Singapore as a healthcare technology firm. Oncology diagnostic solutions powered by AI are developed, incorporating microscopic images and patient data to support clinical decisions. These tools are designed to lower costs for healthcare providers in cancer diagnosis processes. Operations focus on the medical diagnostics sector, with key leadership provided by co-founders Aneesh Sathe as CEO, Kaveh Taghipour as CTO, and Kavita Butalia.
Qritive offers Pantheon, QAi Prostate Services, and Other AI Modules.
Qritive has 4 investors. Key investors include Enterprise Singapore, Exfinity Venture Partners, MassMutual Ventures, and SEEDS Capital.